Circulating Biomarkers May Be Indicative of Stroke Risk

This article originally appeared here.
Share this content:
Circulating Biomarkers May Be Indicative of Stroke Risk
Circulating Biomarkers May Be Indicative of Stroke Risk

THURSDAY, Aug. 25, 2016 (HealthDay News) -- In the future, a simple blood test might gauge a patient's odds of incident ischemic stroke (IIS), according to a study published online Aug. 24 in Neurology.

A team of researchers measured levels of biomarkers in 3,224 individuals. The patients averaged 61 years of age and were tracked for an average of nine years. During that time, 98 of them did suffer IIS.

Elevated levels of four of the biomarkers were linked with increased IIS risk. High blood levels of homocysteine indicated a 32 percent higher risk compared to individuals with the lowest levels. And high levels of three other biomarkers -- vascular endothelial growth factor, C-reactive protein, and tumor necrosis factor receptor 2 -- also indicated a similar heightening of IIS risk, the investigators found.

"Identifying people who are at risk for stroke can help us determine who would benefit most from existing or new therapies to prevent stroke," lead author Ashkan Shoamanesh, M.D., of McMaster University in Hamilton, Canada, said in a journal news release.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

SABCS: Artificial Intelligence May Aid Doctors in Breast Cancer Care

SABCS: Artificial Intelligence May Aid Doctors in Breast ...

'Watson Oncology' agreed with doctors 90 percent of the time in many cases, researchers find

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

SABCS: Scalp-Cooling System Can Reduce Chemo-Related Hair Loss

Devices reduce blood flow to hair follicles during chemotherapy treatments

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

SABCS: Aromatase Inhibitors Tied to Reduced Endothelial Function

Women on aromatase inhibitors exhibit less elasticity in their blood vessels

is free, fast, and customized just for you!

Already a member?

Sign In Now »